medigraphic.com
ISSN 1561-3046 (Electronic)

2013, Number 1

<< Back Next >>

Rev Cub Med Mil 2013; 42 (1)

Value of microalbuminuria in the early detection of chronic kidney disease

Martínez MSM, Del Río BS, Castañer MJ, Casamayor LZ

Language: Spanish
References: 19
Page: 12-20
PDF size: 223.97 Kb.


ABSTRACT

Introduction: chronic kidney disease is a health problem worldwide and it is associated with high incidence of risk factors in our population, such as the presence of microalbuminuria, which has been little studied in healthy people, as well as the evaluation of the renal function through the use of theoretical calculating formulas of the glomerular filtration rate.
Objectives: to characterize the demographic variables and renal function, to determine the predictive value of microalbuminuria and reduced glomerular filtration rate in the present series.
Methods: an observational, analytical and cross section studied was carried out at Dr. Luis Díaz Soto Central Military Hospital. The series consisted of 401 patients. Latex microlab test was used to determine microalbuminuria and GFR was estimated by MDRD-IDMS formula.
Results: the presence of microalbumiuria was found in 22.94 % (n = 92) of the series. Out of the patients with microalbuminuria, 61.95 % (n = 57) aged 20-39 years old. 41.30 % (n = 38) patients were white. Stages I and II were classified of chronic kidney 12.96 % (n = 52) and 9.97 % (n = 40), respectively.
Conclusions: microalbuminuria is a risk factor with predictive value in early stages of chronic kidney disease at an early age.


REFERENCES

  1. Otero A, Gayoso P, García F, De Francisco AL. Epidemiology of chronic renal disease in the Galician population: Results of the pilot Spanish EPIRCE study. Kidney Int Suppl. 2005;16-9.

  2. Marín R, Goicoechea MA, Gorostidi M, Cases A, Díez J, Escolar G, et al. En representación del Comité de Expertos de la Guía de la Sociedad Española de Nefrología (SEN), Riñón y Enfermedad Cardiovascular. Guía de la Sociedad Española de Nefrología sobre Riñón y Enfermedad Cardiovascular. Versión abreviada. Nefrol. 2006;26:31-44. Disponible en: http://www.senefro.org/modules.php?name=calcfg

  3. Renal Data System. USRDS Annual Data Report 2005: Atlas of end-stage renal disease in the Unites States. EE.UU.: Bethesda, MD, National Institutes of Health Dis. 2006;47(Suppl. 1):10-226.

  4. Herrera Valdés R, Pérez-Oliva Díaz JF, Almaguer López M. Cómo mejorar el manejo de la enfermedad renal crónica, consideraciones y recomendaciones prácticas. Rev Haban Cienc Méd. 2008;68 (Supl. 98):66-8.

  5. Donelly R, Yeung JH, Manning G. Microalbuminuria: acammon, independent cardiovascular risk fat epecially but not exclusively in not type 2 diabetes. Hypertens. 2003;21(Supl. 1)7-12.

  6. Levey AS, Eckardt KU, Tsukamoto Y, Levin A. Definición y clasificación de la enfermedad renal crónica: propuesta de KDIGO (Kidney Disease: improving global outcomes). Kidney Int (edición español). 2005;1:135-46.

  7. Gracia S, Montañés R, Bover J, Cases A, Deulofeu R. Documento de consenso: recomendaciones sobre la utilización de ecuaciones para la estimación del filtrado glomerular en adultos. Nefrol. 2006;26:658-65.

  8. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.

  9. Declaración de Helsinki de la Asociación Médica Mundial sobre principios éticos para las investigaciones médicas en seres humanos. 59ª Asamblea General, Seúl, Corea, octubre 2008.

  10. Almaguer López M. Marcadores de daño renal y factores de riesgo asociados para la enfermedad renal diabética. Un estudio de base poblacional. 2007;68(Supl. 98):12-6.

  11. González Maqueda I. La microalbuminuria como factor pronóstico en el enfermo cardiovascular. Rev Esp Cardiol. 2007;7(Supl. A):31-43.

  12. Cándido Mena RN, Velasco J, Angulo E, Garrote T, García Gallego F. Riesgo cardiovascular asociado a microalbuminuria en pacientes diabéticos y en pacientes con hipertensión arterial. Med Clin. 2008;206-9.

  13. De Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the Metabolic Syndrome in American Adolescents. Findings from the third National Health and Nutrition Examination Survey. Circulation. 2005;110:2494-7.

  14. Halimi JM, Hadjadj S, Aboyans V, Allaert FA, Artigou JY, Beaufils M, et al. Microalbuminuria and urinary albumin excretion: clinical practice guidelines. Nephrol Ther. 2007;3(6):384-91.

  15. Paramio Rodríguez A. La microalbuminuria en el diagnóstico precoz del daño renal en el paciente con hipertensión arterial. Rev Nefr Hab. 2007;46(4):4-9.

  16. Diercks GF, van Boven AJ, Hillege HL, Janssen WM, Kors JA, de Jong PE, et al. Microalbuminuria was associated with ischemic electrocardiographic abnormalities in e large non-diabetic population. The PREVEND (Prevention of RRnal and Vascular Endstage Disease) Eur Hearth J. 2000;21(23):1922-7.

  17. Center for Disease Control and Prevention (CDC). Prevalence of chronic kidney disease andassociated risk factor- United states, 1999-2004. 2007;65:161-5.

  18. Mann JFE, Gerstein HC, Pogue J, Bosch J, Yusuff S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med. 2001;134:629-36.

  19. Zappitelli M, Josph L, Gupta IR: Validation of child serum creatinine-based prediction equations for glomerular filtration rate. Pediatr Nephrol. 2009;22(2):167-9.




2020     |     www.medigraphic.com